Group One Trading
BIOR

Group One Trading’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Group One Trading’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,730
Closed -$36.9K – 8312
2023
Q4 		$36.9K Sell
2,730
-60
-2% -$973 ﹤0.01% 5301
2023
Q3 		$60.5K Buy
2,790
+30
+1% +$962 ﹤0.01% 4907
2023
Q2 		$106K Buy
2,760
+330
+14% +$11.6K ﹤0.01% 4560
2023
Q1 		$67.3K Buy
2,430
+1,962
+419% +$66.5K ﹤0.01% 4626
2022
Q4 		$15.4K Sell
468
-327
-41% -$23.8K ﹤0.01% 5768
2022
Q3 		$96K Sell
795
-515
-39% -$92.7K ﹤0.01% 4824
2022
Q2 		$229K Sell
1,310
-188
-13% -$39.6K ﹤0.01% 4159
2022
Q1 		$434K Sell
1,498
-521
-26% -$198K ﹤0.01% 3974
2021
Q4 		$1.05M Buy
2,019
+1,897
+1,555% +$1.36M ﹤0.01% 3305
2021
Q3 		$46K Buy
122
+64
+110% +$27.4K ﹤0.01% 6610
2021
Q2 		$52K Buy
+58
New +$44.4K ﹤0.01% 6550

Group One Trading's BIOR Position: Q4 2023 in Review

Group One Trading sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2023, closing a stake of 470 shares — an estimated $7.62K sold.

Group One Trading first reported a position in BIOR in Q1 2021 and held it in 9 quarters. The position peaked at $129K in Q3 2021. 29 funds tracked by Wall St. Rank hold BIOR as of Q4 2023.

  • Group One Trading reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 470 Biora Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $7.62K.
  • Group One Trading first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Group One Trading's Biora Therapeutics, Inc. Common Stock position peaked at $129K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.